Magnetic resonance imaging for assessment of cerebrovascular reactivity in cerebral small vessel disease: A systematic review

Journal of Cerebral Blood Flow and Metabolism

Volumn 36, Issue 5, 2015, Pages 833-841

  Blair, Gordon W ^a   Doubal, Fergus N ^a   Thrippleton, Michael J ^a   Marshall, Ian ^a   Wardlaw, Joanna M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Blood oxygen level dependent magnetic resonance imaging; cerebral small vessel disease; cerebrovascular reactivity; hypercapnia; white matter hyperintensity

Indexed keywords

AGE; ARTERIAL CARBON DIOXIDE TENSION; BLOOD CARBON DIOXIDE TENSION; BLOOD VESSEL REACTIVITY; BOLD SIGNAL; BRAIN BLOOD FLOW; BREATH HOLDING; CEREBROVASCULAR DISEASE; CEREBROVASCULAR REACTIVITY; CLINICAL CLASSIFICATION; DIASTOLIC BLOOD PRESSURE; GENDER; GRAY MATTER; HUMAN; HYPERVENTILATION; MAGNETIC FIELD; MICROBLEED ANATOMICAL RATING SCALE; NERVOUS SYSTEM PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PATIENT SAFETY; PERIVASCULAR SPACE; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; REVIEW; SYSTEMATIC REVIEW; WHITE MATTER; WHITE MATTER HYPERINTENSITY; BLOOD; BRAIN CIRCULATION; DIAGNOSTIC IMAGING; PATHOPHYSIOLOGY; PROCEDURES;

OXYGEN;

CEREBRAL SMALL VESSEL DISEASES; CEREBROVASCULAR CIRCULATION; HUMANS; MAGNETIC RESONANCE IMAGING; OXYGEN;

EID: 84964963303     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X16631756     Document Type: Review

References (29)

1. Wardlaw JM, Smith C and Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neu-roimaging. Lancet Neurol 2013; 12: 483-497.
2. Debette SM. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010; 341: c3666.
3. Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013; 12: 822-838.
4. Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer disease: the Nun Study. JAMA 1997; 277: 813-817.
5. Khan U, Porteous L, Hassan A, et al. Risk factor profile of cerebral small vessel disease and its subtypes. J Neurol Neurosurg Psychiatry 2007; 78: 702-706.
6. Wardlaw JM, Allerhand M, Doubal FN, et al. Vascular risk factors, large-artery atheroma, and brain white matter hyperintensities. Neurology 2014; 82: 1331-1338.
7. Jackson C and Sudlow C. Comparing risks of death and recurrent vascular events between lacunar and non-lacu-nar infarction. Brain 2005; 128: 2507-2517.
8. Staals J, Booth T, Morris Z, et al. Total MRI load of cerebral small vessel disease and cognitive ability in older people. Neurobiol Aging 2015; 36: 2806-2811.
9. Bailey EL, Smith C, Sudlow CL, et al. Pathology of lacunar ischemic stroke in humans-a systematic review. Brain Pathol 2012; 22: 583-591.
10. Gouw AA, Seewann A, van der Flier WM, et al. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 2011; 82: 126-135.
11. Stevenson SF, Doubal FN, Shuler K, et al. A systematic review of dynamic cerebral and peripheral endothelial function in lacunar stroke versus controls. Stroke 2010; 41: e434-e442.
12. Fierstra J, Sobczyk O, Battisti-Charbonney A, et al. Measuring cerebrovascular reactivity: what stimulus to use? J Physiol 2013; 591: 5809-5821.
13. Mandell DM, Han JS, Poublanc J, et al. Mapping cerebrovascular reactivity using blood oxygen level-dependent MRI in patients with arterial steno-occlusive disease: comparison with arterial spin labeling MRI. Stroke 2008; 39: 2021-2028.
14. Ziyeh S, Rick J, Reinhard M, et al. Blood oxygen level-dependent MRI of cerebral CO2 reactivity in severe carotid stenosis and occlusion. Stroke 2005; 36: 751-756.
15. Gauthier CJ, Lefort M, Mekary S, et al. Hearts and minds: linking vascular rigidity and aerobic fitness with cognitive aging. Neurobiol Aging 2015; 36: 304-314.
16. Richiardi J, Monsch AU, Haas T, et al. Altered cerebrovascular reactivity velocity in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2015; 36: 33-41.
17. Conijn MM, Hoogduin JM, van der Graaf Y, et al. Microbleeds, lacunar infarcts, white matter lesions and cerebrovascular reactivity-a 7 T study. Neuroimage 2012; 59: 950-956.
18. Yezhuvath US, Uh J, Cheng Y, et al. Forebrain-dominant deficit in cerebrovascular reactivity in Alzheimer's disease. Neurobiol Aging 2012; 33: 75-82.
19. Hund-Georgiadis M, Zysset S, Naganawa S, et al. Determination of cerebrovascular reactivity by means of FMRI signal changes in cerebral microangiopathy: a correlation with morphological abnormalities. Cerebrovasc Dis 2003; 16: 158-165.
20. Gregoire SM, Chaudhary UJ, Brown MM, et al. The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology 2009; 73: 1759-1766.
21. Thomas BP, Liu P, Park DC, et al. Cerebrovascular reactivity in the brain white matter: magnitude, temporal characteristics, and age effects. J Cereb Blood Flow Metab 2014; 34: 242-247.
22. Hsu YY, Kuan WC, Lim KE, et al. Breathhold-regulated blood oxygenation level-dependent (BOLD) MRI of human brain at 3 tesla. J Magn Reson Imag 2010; 31: 78-84.
23. Rostrup E, Larsson HBW, Toft PB, et al. Functional MRI of CO2 induced increase in cerebral perfusion. NMR Biomed 1994; 7: 29-34.
24. Wardlaw J, Brindle W, Casado A, et al. A systematic review of the utility of 1.5 versus 3 Tesla magnetic resonance brain imaging in clinical practice and research. Eur Radiol 2012; 22: 2295-2303.
25. Bhogal A, Siero JC, Fisher JA, et al. Investigating the non-linearity of the BOLD cerebrovascular reactivity response to targeted hypo/hypercapnia at 7T. Neuroimage 2014; 98: 296-305.
26. Hare HV, Germuska M, Kelly ME, et al. Comparison of CO2 in air versus carbogen for the measurement of cere-brovascular reactivity with magnetic resonance imaging. J Cereb Blood Flow Metab 2013; 33: 1799-1805.
27. Tancredi FB and Hoge RD. Comparison of cerebral vascular reactivity measures obtained using breath-holding and CO2 inhalation. J Cereb Blood Flow Metab 2013; 33: 1066-1074.
28. Zande FH, Hofman PA and Backes WH. Mapping hypercapnia-induced cerebrovascular reactivity using BOLD MRI. Neuroradiology 2005; 47: 114-120.
29. Spano VR, Mandell DM, Poublanc J, et al. CO2 blood oxygen level-dependent MR mapping of cerebrovascular reserve in a clinical population: safety, tolerability, and technical feasibility. Radiology 2013; 266: 592-598.